Biotechnology
Spain: A Potential Market for Biotechnology
By Javier Amayra
CEO of Hiperion Biotech
Hiperion Biotech
Life sciences and biotechnology are, after information technologies, the next wave of technological revolution that will bring important advances in the well being of our societies.
Generic Pharmaceutical Specialities (GPS) in Spain
By Juan Uriarte
Hiperion Biotech Consultant
Hiperion Biotech
Introduction and definitions: This group of medicines was created in Spain under Law 13/1996 for Fiscal, Administrative and Social Measures from December 30th 1996 which, in its chapter III, modifies certain points in the Law of Medicaments.
HPA Achieves Major Success in Obtaining US Biodefence Funding
By Dr Phil Luton
Business Development & Communications, Health Protection Agency
Health Protection Agency
Direct Government Funding
Biotechnology in Argentina
By Javier Amayra
CEO of Hiperion Biotech
Hiperion Biotech
Those of us who live in the more highly-developed countries frequently tend to believe that technology belongs to only a few countries, usually located in the northern hemisphere.
Economic Evaluation Of The Lifesciences Sector Set
By BioApproaches SW
The South West of England is a major centre of biotechnology excellence with internationally recognised expertise covering everything from marine and environmental technologies, pharmaceuticals for healthcare to food technology.
Biotechnology Faculty of the Year Award
By North Carolina Biotechnology Center
Biotechnology Center and Industry Launch Award To Honor Community Colleges’ Martin Lancaster
British MP Visits North Carolina Biotechnology Center and Other RTP Institutions
By North Carolina Biotechnology Center
British Member of Parliament John Denham Visits RTP Seeking Links Between Education, Innovation, Venture
